Roche says Herceptin approved in Japan for breast cancer - MarketWatch

dBTechno Roche says Herceptin approved in Japan for breast cancer MarketWatch - 18 hours ago By Zurich Bureau , , ) said Friday Herceptin has been approved in Japan for early treatment in patients with HER2-positive breast cancer . ... Japan clears Herceptin for breast cancer : Roche Reuters Genentech, Glaxo Treatments Will Compete in Breast Cancer Study Bloomberg New study to compare Genentech's Herceptin vs. Glaxo's Tykerb MarketWatch dBTechno  - Reuters all 27 news articles

full article | source